Common use of Designation and Principal Amount Clause in Contracts

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.450% Notes due 2028,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 Notes to be issued on the date hereof is set forth in Article Thirteen herein.

Appears in 1 contract

Samples: Pfizer Inc

AutoNDA by SimpleDocs

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4505.300% Notes due 20282053,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 2053 Notes to be issued on the date hereof is set forth in Article Thirteen herein.

Appears in 1 contract

Samples: Pfizer Inc

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4503.250% Notes due 20282042,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 2042 Notes to be issued on the date hereof is shall be as set forth in Article Thirteen hereinany Company Order for the authentication and delivery of the 2042 Notes, pursuant to Section 303 of the Base Indenture.

Appears in 1 contract

Samples: Supplemental Indenture (Bristol Myers Squibb Co)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4502.000% Notes due 20282022,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 2022 Notes to be issued on the date hereof is shall be as set forth in Article Thirteen hereinany Company Order for the authentication and delivery of the 2022 Notes, pursuant to Section 303 of the Base Indenture.

Appears in 1 contract

Samples: Supplemental Indenture (Bristol Myers Squibb Co)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4505.450% Notes due 20282034,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 2034 Notes to be issued on the date hereof is set forth in Article Thirteen X herein.

Appears in 1 contract

Samples: Cardinal Health Inc

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4504.650% Notes due 20282030,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 2030 Notes to be issued on the date hereof is set forth in Article Thirteen herein.

Appears in 1 contract

Samples: Pfizer Inc

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4504.700% Notes due 20282029,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 2029 Notes to be issued on the date hereof is set forth in Article Thirteen IX herein.

Appears in 1 contract

Samples: BlackRock Inc.

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4504.750% Notes due 2028December 15, 2023,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 Notes to be issued on the date hereof is shall be as set forth in Article Thirteen hereinany Company order for the authentication and delivery of the Notes, pursuant to Section 2.4 of the Indenture.

Appears in 1 contract

Samples: Indenture (KOHLS Corp)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.450% Notes due 20282026,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 2026 Notes to be issued on the date hereof is set forth in Article Thirteen herein.

Appears in 1 contract

Samples: Pfizer Inc

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4504.700% Notes due 2028,” October 1, 2019”, which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 Notes to be issued on the date hereof is shall be as set forth in Article Thirteen hereinany Company Order for the authentication and delivery of the Notes, pursuant to Section 303 of the Indenture.

Appears in 1 contract

Samples: Fourth Supplemental Indenture (Burlington Northern Santa Fe Corp)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4504.20% Notes due 2028,” 2047”, which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 Notes to be issued on the date hereof is set forth in Article Thirteen Six herein.

Appears in 1 contract

Samples: Eighth Supplemental Indenture (Pfizer Inc)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4504.000% Notes NOTES due 2028,” November 1, 2021”, which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 Notes to be issued on the date hereof is shall be as set forth in Article Thirteen hereinany Company order for the authentication and delivery of the Notes, pursuant to Section 2.4 of the Indenture.

Appears in 1 contract

Samples: KOHLS Corp

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4505.340% Notes due 20282063,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 2063 Notes to be issued on the date hereof is set forth in Article Thirteen herein.

Appears in 1 contract

Samples: Pfizer Inc

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4505.110% Notes due 20282043,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 2043 Notes to be issued on the date hereof is set forth in Article Thirteen herein.

Appears in 1 contract

Samples: Pfizer Inc

AutoNDA by SimpleDocs

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4503.550% Notes due 20282042,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 2042 Notes to be issued on the date hereof is shall be as set forth in Article Thirteen hereinany Company Order for the authentication and delivery of the 2042 Notes, pursuant to Section 303 of the Base Indenture.

Appears in 1 contract

Samples: Indenture (Bristol Myers Squibb Co)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4505.75% Notes due 2028,” March 15, 2018”, which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 Notes to be issued on the date hereof is shall be as set forth in Article Thirteen hereinany Company order for the authentication and delivery of the Notes, pursuant to Section 303 of the Indenture.

Appears in 1 contract

Samples: Indenture (Burlington Northern Santa Fe Corp)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4504.750% Notes due 20282033,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 2033 Notes to be issued on the date hereof is set forth in Article Thirteen herein.

Appears in 1 contract

Samples: Pfizer Inc

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4505.250% Notes due 20282054,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 2054 Notes to be issued on the date hereof is set forth in Article Thirteen IX herein.

Appears in 1 contract

Samples: BlackRock Inc.

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4504.650% Notes due 20282025,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 2025 Notes to be issued on the date hereof is set forth in Article Thirteen herein.

Appears in 1 contract

Samples: Pfizer Inc

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4503.700% Notes due 20282052,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 2052 Notes to be issued on the date hereof is shall be as set forth in Article Thirteen hereinany Company Order for the authentication and delivery of the 2052 Notes, pursuant to Section 303 of the Base Indenture.

Appears in 1 contract

Samples: Indenture (Bristol Myers Squibb Co)

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4503.250% Notes due 2028February 1, 2023,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 Notes to be issued on the date hereof is shall be as set forth in Article Thirteen hereinany Company order for the authentication and delivery of the Notes, pursuant to Section 2.4 of the Indenture.

Appears in 1 contract

Samples: KOHLS Corp

Designation and Principal Amount. There is hereby authorized and established a series of Securities under the Indenture, designated as the “4.4503.900% Notes due 20282062,” which is not limited in aggregate principal amount. The aggregate principal amount of the 2028 2062 Notes to be issued on the date hereof is shall be as set forth in Article Thirteen hereinany Company Order for the authentication and delivery of the 2062 Notes, pursuant to Section 303 of the Base Indenture.

Appears in 1 contract

Samples: Indenture (Bristol Myers Squibb Co)

Time is Money Join Law Insider Premium to draft better contracts faster.